In the Annals of Internal Medicine, a general internal medicine physician and a urologist discuss treatment plans for benign prostatic hyperplasia (BPH) and how they would apply their recommendations to a patient who wishes ...
Apr 12, 2023
0
5
New research from the University of Hertfordshire has underscored the disparities in mental health support for adults with kidney disease, recommending specialist, culturally-adapted approaches for South Asian patients who ...
Apr 11, 2023
0
6
An emulated randomized trial performed using observational data from more than 43,000 adults with primary hyperparathyroidism found that parathyroidectomy had no estimated effect on long-term kidney function in older adults ...
Apr 10, 2023
0
7
Adults hospitalized with the SARS-CoV-2 omicron variant have a higher death rate than those hospitalized with seasonal influenza, even though omicron is considered less virulent with lower case fatality rates than the delta ...
Apr 7, 2023
1
2
Chronic kidney disease (CKD) is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. Despite the disease's prevalence—10 percent of individuals across the globe suffer from CKD—there ...
Apr 4, 2023
0
49
The prevalence of multimorbidity, the co-occurrence of two or more chronic conditions, varies depending on exactly how it is defined. And the health care costs associated with many disease combinations cost more together ...
Apr 4, 2023
0
20
A new study published in the Journal of American Medical Directors (JAMDA) found that the risk of severe COVID-19 illness among nursing home residents with complete vaccination are low. The study found that residents aged ...
Apr 3, 2023
0
33
In a new study looking at the long-term effects of hospitalized patients who have acute kidney injury (AKI), a sudden but temporary loss of kidney function, Johns Hopkins Medicine researchers found that higher levels of certain ...
Apr 3, 2023
0
17
Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially lethal genetic disease—about a half million people in the United States alone suffer from the condition. There is no cure, but new research ...
Apr 3, 2023
0
41
The latest findings from the PROTECT phase III trial show sparsentan—a novel treatment for IgA nephropathy—significantly reduces proteinuria, or abnormal protein levels in the urine, compared to standard treatment irbesartan.
Apr 3, 2023
0
78
